These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24086465)

  • 1. Development of a new DNA vaccine for Alzheimer disease targeting a wide range of aβ species and amyloidogenic peptides.
    Matsumoto Y; Niimi N; Kohyama K
    PLoS One; 2013; 8(9):e75203. PubMed ID: 24086465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing Th2 immune responses against amyloid protein by a DNA prime-adenovirus boost regimen for Alzheimer's disease.
    Kim HD; Jin JJ; Maxwell JA; Fukuchi K
    Immunol Lett; 2007 Sep; 112(1):30-8. PubMed ID: 17686533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of non-viral amyloid-β DNA vaccines on amyloid-β reduction and safety in rhesus monkeys.
    Tokita Y; Kaji K; Lu J; Okura Y; Kohyama K; Matsumoto Y
    J Alzheimers Dis; 2010; 22(4):1351-61. PubMed ID: 20930304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low concentrations of anti-Aβ antibodies generated in Tg2576 mice by DNA epitope vaccine fused with 3C3d molecular adjuvant do not affect AD pathology.
    Movsesyan N; Davtyan H; Mkrtichyan M; Petrushina I; Tiraturyan T; Ross T; Agadjanyan MG; Ghochikyan A; Cribbs DH
    Hum Gene Ther; 2010 Nov; 21(11):1569-76. PubMed ID: 20528468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic Vaccine Based on Pyroglutamate-3 Amyloid β Generates Strong Antibody Response and Rescues Cognitive Decline in Alzheimer's Disease Model Mice.
    Li G; Hu ZW; Chen PG; Sun ZY; Chen YX; Zhao YF; Li YM
    ACS Chem Neurosci; 2017 Mar; 8(3):454-459. PubMed ID: 28292186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strikingly reduced amyloid burden and improved behavioral performance in Alzheimer's disease mice immunized with recombinant chimeric vaccines by hexavalent foldable Aβ₁₋₁₅ fused to toxin-derived carrier proteins.
    Yu YZ; Wang WB; Chen A; Chang Q; Liu S; Zhao M; Wang S; Qiu WY; Pang XB; Xu Q; Sun ZW
    J Alzheimers Dis; 2014; 41(1):243-60. PubMed ID: 24625800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and preclinical evaluation of the cGMP grade DNA based vaccine, AV-1959D to enter the first-in-human clinical trials.
    Petrushina I; Hovakimyan A; Harahap-Carrillo IS; Davtyan H; Antonyan T; Chailyan G; Kazarian K; Antonenko M; Jullienne A; Hamer MM; Obenaus A; King O; Zagorski K; Blurton-Jones M; Cribbs DH; Lander H; Ghochikyan A; Agadjanyan MG
    Neurobiol Dis; 2020 Jun; 139():104823. PubMed ID: 32119976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies from a DNA peptide vaccination decrease the brain amyloid burden in a mouse model of Alzheimer's disease.
    Schiltz JG; Salzer U; Mohajeri MH; Franke D; Heinrich J; Pavlovic J; Wollmer MA; Nitsch RM; Moelling K
    J Mol Med (Berl); 2004 Oct; 82(10):706-14. PubMed ID: 15241501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abeta DNA vaccination for Alzheimer's disease: focus on disease prevention.
    Cribbs DH
    CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):207-16. PubMed ID: 20205639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformation-sensitive antibodies against alzheimer amyloid-beta by immunization with a thioredoxin-constrained B-cell epitope peptide.
    Moretto N; Bolchi A; Rivetti C; Imbimbo BP; Villetti G; Pietrini V; Polonelli L; Del Signore S; Smith KM; Ferrante RJ; Ottonello S
    J Biol Chem; 2007 Apr; 282(15):11436-45. PubMed ID: 17267402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. I32E and V36K double mutation in beta2-sheet abrogates amyloid beta peptide toxicity.
    Subramanian S; Mishra PK; Bandopadhyay D
    Indian J Exp Biol; 2010 Nov; 48(11):1098-102. PubMed ID: 21117449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA immunization with HBsAg-based particles expressing a B cell epitope of amyloid β-peptide attenuates disease progression and prolongs survival in a mouse model of Alzheimer's disease.
    Olkhanud PB; Mughal M; Ayukawa K; Malchinkhuu E; Bodogai M; Feldman N; Rothman S; Lee JH; Chigurupati S; Okun E; Nagashima K; Mattson MP; Biragyn A
    Vaccine; 2012 Feb; 30(9):1650-8. PubMed ID: 22248819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination induced changes in pro-inflammatory cytokine levels as an early putative biomarker for cognitive improvement in a transgenic mouse model for Alzheimer disease.
    Lin X; Bai G; Lin L; Wu H; Cai J; Ugen KE; Cao C
    Hum Vaccin Immunother; 2014; 10(7):2024-31. PubMed ID: 25424812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of DNA- and recombinant protein-based Alzheimer disease epitope vaccines.
    Davtyan H; Bacon A; Petrushina I; Zagorski K; Cribbs DH; Ghochikyan A; Agadjanyan MG
    Hum Vaccin Immunother; 2014; 10(5):1248-55. PubMed ID: 24525778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of epitopes combination and adjuvants on immune responses to anti-Alzheimer disease DNA vaccines in mice.
    He Y; Sun SH; Chen RW; Guo YJ; He XW; Huang L; Chen ZH; Shi K; Zhu WJ
    Alzheimer Dis Assoc Disord; 2005; 19(4):171-7. PubMed ID: 16327342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active immunization with norovirus P particle-based amyloid-β chimeric protein vaccine induces high titers of anti-Aβ antibodies in mice.
    Yang P; Guo Y; Sun Y; Yu B; Zhang H; Wu J; Yu X; Wu H; Kong W
    BMC Immunol; 2019 Feb; 20(1):9. PubMed ID: 30755174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal inoculation of an adenovirus vector encoding 11 tandem repeats of Abeta1-6 upregulates IL-10 expression and reduces amyloid load in a Mo/Hu APPswe PS1dE9 mouse model of Alzheimer's disease.
    Kim HD; Tahara K; Maxwell JA; Lalonde R; Fukuiwa T; Fujihashi K; Van Kampen KR; Kong FK; Tang DC; Fukuchi K
    J Gene Med; 2007 Feb; 9(2):88-98. PubMed ID: 17219449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developing novel immunogens for a safe and effective Alzheimer's disease vaccine.
    Lemere CA
    Prog Brain Res; 2009; 175():83-93. PubMed ID: 19660650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a safe oral Abeta vaccine using recombinant adeno-associated virus vector for Alzheimer's disease.
    Hara H; Monsonego A; Yuasa K; Adachi K; Xiao X; Takeda S; Takahashi K; Weiner HL; Tabira T
    J Alzheimers Dis; 2004 Oct; 6(5):483-8. PubMed ID: 15505369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An aqueous orally active vaccine targeted against a RAGE/AB complex as a novel therapeutic for Alzheimer's disease.
    Webster SJ; Mruthinti S; Hill WD; Buccafusco JJ; Terry AV
    Neuromolecular Med; 2012 Jun; 14(2):119-30. PubMed ID: 22415896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.